Issuer Free Writing Prospectus
Filed Pursuant to Rule 433
Registration Statement No. 333-136910
FINAL PRICING TERMS
October 26, 2006
|
|
|
Issuer:
|
|
Critical Therapeutics, Inc. (NASDAQ: CRTX). |
|
|
|
Securities Offered:
|
|
Units consisting of one share of common stock
and a warrant to purchase 0.5 shares of common stock,
exercisable on or before October 26, 2011 at an
exercise price of $2.62 per share of common stock |
|
|
|
Maximum Number of
Units
|
|
7,455,731 |
|
|
|
Price Per Unit
|
|
$2.6825 per unit |
|
|
|
Estimated net
Proceeds
|
|
$19,999,998 |
|
|
|
The issuer has filed a registration statement (including a prospectus) with the SEC for the
offering to which this communication relates. Before you invest, you should read the prospectus in
that registration statement and other documents the issuer has filed with the SEC for more complete
information about the issuer and this offering. You may get these documents for free by visiting
EDGAR on the SEC website at www.sec.gov. Alternatively the issuer and the placement agent will
arrange to send you the prospectus if you request it by calling
212-632-6717.